Novel Agents and Combinations in Hodgkin Lymphoma
0 Ansichten
• 07/09/23
0
0
Einbetten
administrator
Abonnenten
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare